(Q40339381)

19 September 2017

title

The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding (English)

1 reference

19 September 2017

1 reference

Cryptococcus neoformans

1 reference

5

Arturo Casadevall

1 reference

19 September 2017

4

Ekaterina Dadachova

1 reference

19 September 2017

Oscar Zaragoza

1

1 reference

19 September 2017

Andrew Telzak

series ordinal

2

1 reference

19 September 2017

Ruth A Bryan

series ordinal

3

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

19 September 2017

published in

Molecular Microbiology

1 reference

19 September 2017

volume

59

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

67-83

1 reference

Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Biosynthesis of UDP-GlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

A yeast under cover: the capsule of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

How does Cryptococcus get its coat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Antibody interactions with the capsule of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Molecular architecture of the Cryptococcus neoformans capsule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Spatial and temporal sequence of capsule construction in Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

An alpha-1,3-mannosyltransferase of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Regulation of cryptococcal capsular polysaccharide by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Experimental modulation of capsule size in Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

Induction of Capsule Growth inCryptococcus neoformansby Mammalian Serum and CO2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2005.04928.X

10.1111/J.1365-2958.2005.04928.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference